| Title |
Benefit–risk assessment of new and emerging treatments for hepatitis C: focus on simeprevir and sofosbuvir
|
|---|---|
| Published in |
Drug, Healthcare and Patient Safety, March 2014
|
| DOI | 10.2147/dhps.s43304 |
| Pubmed ID | |
| Authors |
John N Gaetano |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Argentina | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 2 | 67% |
| Members of the public | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 2% |
| Pakistan | 1 | 2% |
| Unknown | 45 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 9 | 19% |
| Researcher | 8 | 17% |
| Student > Bachelor | 6 | 13% |
| Student > Doctoral Student | 6 | 13% |
| Student > Ph. D. Student | 6 | 13% |
| Other | 11 | 23% |
| Unknown | 1 | 2% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 24 | 51% |
| Agricultural and Biological Sciences | 10 | 21% |
| Chemistry | 4 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
| Nursing and Health Professions | 1 | 2% |
| Other | 4 | 9% |
| Unknown | 2 | 4% |
Attention Score in Context
This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 November 2015.
All research outputs
#2,011,571
of 25,457,858 outputs
Outputs from Drug, Healthcare and Patient Safety
#11
of 160 outputs
Outputs of similar age
#19,906
of 236,521 outputs
Outputs of similar age from Drug, Healthcare and Patient Safety
#2
of 6 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 160 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 236,521 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.